Milestone Pharmaceuticals Inc. (MIST)

NASDAQ: MIST · Real-Time Price · USD

1.740

+0.090 (5.45%)

At close: Jun 5, 2025, 4:00 PM

1.700

-0.040 (-2.30%)

After-hours: Jun 5, 2025, 7:36 PM EDT

Milestone Pharmaceuticals Employees

Milestone Pharmaceuticals had 33 employees as of December 31, 2024. The number of employees decreased by 14 or -29.79% compared to the previous year.

Employees

33

Change (1Y)

-14

Growth (1Y)

-29.79%

Revenue / Employee

n/a

Profits / Employee

-$1,573,515

Market Cap

115.49M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	33	-14	-29.79%
Dec 31, 2023	47	8	20.51%
Dec 31, 2022	39	10	34.48%
Dec 31, 2021	29	1	3.57%
Dec 31, 2020	28	-2	-6.67%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

MIST News

8 days ago - Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
22 days ago - Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
2 months ago - Stock Picks From Seeking Alpha's March 2025 New Analysts - Seeking Alpha
2 months ago - Milestone Pharmaceuticals Shares Hit New Low After FDA Rejects Etripamil - Market Watch
2 months ago - US FDA declines to approve Milestone Pharma's heart rhythm nasal spray - Reuters
2 months ago - FDA Issues Complete Response Letter for Etripamil for PSVT - GlobeNewsWire
2 months ago - Milestone Pharmaceuticals: A Compelling Value Proposition For Patients And Payers - Seeking Alpha
2 months ago - Milestone Pharmaceuticals to Present Clinical Data on Etripamil at the American College of Cardiology - GlobeNewsWire